Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
By Sydney Price · January 16, 2026, 7:30 PM EST
Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login